Ask the Expert: Emerging New Tool to Monitor Melanoma


Dr. Alan Tan

Director of Genitourinary Oncology Program & Co-Lead of the Precision Medicine Program Rush University Medical Center

Dr. Alan Tan is director of the genitourinary oncology program at Rush University medical center and co-leads the precision medicine program.  He is co-chair of the Hoosier cancer research network melanoma working group.  He also serves as the genitourinary executive officer for the Alliance for Clinical Trials in Oncology.  His research interests include biomarker development for melanoma and genitourinary malignancies.


Post-webinar evaluation
4 Questions
Ask the Expert: Emerging New Tool to Monitor Melanoma
Recorded 09/08/2023  |  60 minutes
Recorded 09/08/2023  |  60 minutes We are pleased to have you join us today for this wonderful educational opportunity entitled Emerging New Tool to Monitor Melanoma. The goal today is to educate patients and the community on tumor-informed ctDNA as an option for residual disease detection, treatment response monitoring, and surveillance. Our mission at the MRF is to eradicate melanoma by accelerating research while educating to and advocating for the melanoma community. We know that education is critical for patients to make informed decisions about their care. We are grateful to Natera for their generous support of this webinar series and investment in the MRF’s mission.